113 results
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
injury to the Company; (iii) unauthorized use or disclosure by the Participant of any proprietary information or trade secrets of the Company or any other
8-K
EX-10.3
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
, detrimental reliance, invasion of privacy, nonphysical injury, personal injury or sickness, or any other harm, wrongful or retaliatory discharge … not suffered or incurred any workplace injury in the course of Executive’s employment with the Company, other than any injury that was made the subject
8-K
EX-10.3
LFCR
Lifecore Biomedical Inc
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
a limit of USD [* * *] Bodily Injury/Property Damage Liability per occurrence and in the aggregate. 8.08 NEITHER PARTY SHALL BE LIABLE TO THE OTHER
8-K
EX-10.5
LFCR
Lifecore Biomedical Inc
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
(including blanket contractual liability coverage and products liability coverage) for personal and bodily injury and property damage per occurrence … the Lease Documents (c) Lessee’s operation or use of any Equipment, including any injury to persons, property or the environment arising directly from
8-K
EX-10.1
21mcq3an ipr6
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.6
vgfr8jqtrgfc d4
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.2
hdcyf e0ym
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
yldy7q
10 Aug 22
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
4:20pm
8-K
EX-10.1
zmet0 j4vnx
15 Oct 21
Departure of Directors or Certain Officers
4:04pm
8-K
EX-10.1
o18a11bku86q6
2 Jun 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
1mhy2uu
8 Mar 21
Departure of Directors or Certain Officers
5:27pm
8-K
EX-10.1
p2vb4avdd4g5pon8snqn
2 Feb 21
Departure of Directors or Certain Officers
12:37pm
8-K
EX-10.1
daph0 gual
20 Jan 21
Landec Appoints New Chief Financial Officer
5:07pm
8-K
EX-10.3
fdrdg rp3
5 Jan 21
Landec Corporation Announces Comprehensive Refinancing of Credit Facilities
3:00pm
8-K
EX-10.1
zzb2dvo81t0g
5 Jan 21
Landec Corporation Announces Comprehensive Refinancing of Credit Facilities
3:00pm
8-K
EX-10.1
bfuys8i
24 Aug 20
Landec Nominates Three New Members to its Board of Directors, Providing
8:25am